Related Experiment Videos

Severe hepatitis B in infants born to HBsAg carrier mothers

Insights

Severe hepatitis B in infants born to carrier mothers can lead to acute liver failure. Prompt exchange transfusion and supportive care may improve survival rates for these infants.

Area of Science:

  • Pediatrics
  • Hepatology
  • Infectious Diseases

Background:

  • Hepatitis B virus (HBV) infection in infants born to HBsAg-positive mothers poses a significant risk.
  • Neonatal HBV infection can progress to severe hepatitis and acute liver failure.
  • Hepatitis B immune globulin (HBIG) is used for prophylaxis, but outcomes in severe cases require further investigation.

Purpose of the Study:

  • To evaluate the efficacy of exchange transfusion and supportive care in infants with severe hepatitis B.
  • To analyze the outcomes of infants born to HBsAg carrier mothers who developed acute liver failure.

Main Methods:

  • Retrospective analysis of five consecutive infants with severe hepatitis B.
  • Treatment included exchange transfusion, correction of coagulation defects, and intensive supportive measures.
  • All infants were born to HBsAg carrier mothers; one received HBIG post-birth.

Main Results:

  • Three out of five infants survived with full recovery.
  • Two infants died from hepatic encephalopathy within one to two weeks of admission.
  • Initial symptoms included vomiting, loose stools, and low-grade fever, progressing to liver failure.

Conclusions:

  • Early recognition of hepatic failure is crucial for timely intervention.
  • Exchange transfusion combined with intensive supportive treatment may improve survival in severe neonatal hepatitis B.
  • Despite interventions, mortality remains a concern in fulminant hepatic failure cases.

Related Concept Videos